anmelden
OMX Stockholm 30
3.061,49
PKT
+5,97
PKT
+0,20
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.06.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 06.06.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.06.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 27.05.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 26.05.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
| 25.05.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.05.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 24.05.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 24.05.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 23.05.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 19.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 19.05.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 19.05.22 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 18.05.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 17.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 17.05.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 11.05.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 03.05.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 03.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 03.05.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 02.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.04.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.04.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 28.04.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 27.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 26.04.22 | Volvo (B) Sell | UBS AG | |
| 25.04.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 25.04.22 | Volvo (B) Buy | Deutsche Bank AG | |
| 22.04.22 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 22.04.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 22.04.22 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 22.04.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 22.04.22 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 22.04.22 | Volvo (B) Neutral | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.